IGC Pharma, Inc.
IGC· NYSE
IGCIGC Pharma, Inc.
Filed Jul 14, 2015 · 10-K · 105 days after period end · 0001185185-15-001808
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $2.26M | — | $779.82K |
| Net Income | -$1.94M | -$1.46M | -$17.04M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
IGC Pharma, Inc. · CIK 1326205 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed Jul 14, 2015 · 105 d after period end
